Echo Therapeutics Publicates of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System
Advertisement
Echo Therapeutics announced publication of results from three pilot clinical studies of its Symphony Transdermal Continuous glucose Monitoring (tCGM) System in the Journal of Diabetes Science and Technology. The article highlights that each of the three pilot clinical studies produced positive results supporting the use of Echo's Symphony(TM) tCGM System for reliable, non-invasive, real-time continuous glucose monitoring, and its most recently developed skin permeation device, the Prelude(TM) SkinPrep System.
"The data from our pilot feasibility studies to date support our late-stage development programs of our Symphony tCGM System for use in diabetes and hospital markets," stated Patrick Mooney, M.D., Echo's Chairman and CEO. "We have made substantial progress with Symphony over the past nine months. This article emphasizes that progress and the potential of our Symphony System to assist diabetics and healthcare professionals to improve glycemic control and reduce the rate of short- and long-term complications."
"Tight glycemic control through continuous glucose monitoring is essential for patients in diverse settings, including for both diabetics at home and hospitalized patients in critical care conditions," said Stanley Nasraway, M.D., Director of Surgical Intensive Care Units at Tufts Medical Center, Principal Investigator and corresponding author of the published studies. "The Symphony tCGM System, with continuing development, offers a potentially safe and efficacious option that is non-invasive and easy to use in both settings."
Other news from the department research and development
Most read news
More news from our other portals
Last viewed contents
Biosynth Extends its Offering to Multi-Kilogram GMP Peptide Synthesis through the Acquisition of Pepceuticals
Intercell reports Phase II Study Results of its Vaccine Enhancement Patch for Pandemic Influenza
BTG: Study Shows Abiraterone Can Successfully Treat Aggressive, Chemotherapy-Resistant Prostate Cancer
SEQUENOM and National Institutes of Health Expand Relationship for Gene Expression - Agreement Builds on Success of Previous SNP Genotyping Research
Muscle-Targeted Gene Therapy Reverses Rare Muscular Dystrophy in Mice
Study finds 'mad cow disease' in cattle can spread widely in ANS before detectable in CNS
Simple and Fast Method for Radiolabelling Antibodies against Breast Cancer - Using UV light, radiolabelled antibodies can be produced in just 15 minutes
Bioactive natural compounds for the fight against cancer - New synthesis route manages without toxic and expensive oxidizing agent and at the same time proves to be much more efficient
Genzyme Receives Approval for Additional Manufacturing at Ireland Plant - Thymoglobulin Fill/Finishing to Begin Immediately
A fruit a day may keep Alzheimer's at bay, suggests new Cornell study
Ear wax as a possible screening medium for Parkinson’s disease
